Cite
HARVARD Citation
Chou, A. et al. (n.d.). Combination of CDK4/6 inhibitor PD-0332991 with standard chemotherapy is synergistic in RB high pancreatic cancer. European journal of cancer. pp. S182-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chou, A. et al. (n.d.). Combination of CDK4/6 inhibitor PD-0332991 with standard chemotherapy is synergistic in RB high pancreatic cancer. European journal of cancer. pp. S182-. [Online].